These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1381352)

  • 21. Removal of 14 N-terminal amino acids of lactoferrin enhances its affinity for parenchymal liver cells and potentiates the inhibition of beta- very low density lipoprotein binding.
    Ziere GJ; Bijsterbosch MK; van Berkel TJ
    J Biol Chem; 1993 Dec; 268(36):27069-75. PubMed ID: 7903302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolism of activated complement component C3 is mediated by the low density lipoprotein receptor-related protein/alpha(2)-macroglobulin receptor.
    Meilinger M; Gschwentner C; Burger I; Haumer M; Wahrmann M; Szollar L; Nimpf J; Huettinger M
    J Biol Chem; 1999 Dec; 274(53):38091-6. PubMed ID: 10608878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of apolipoprotein C-I peptides on the apolipoprotein E content and receptor-binding properties of beta-migrating very low density lipoproteins.
    Swaney JB; Weisgraber KH
    J Lipid Res; 1994 Jan; 35(1):134-42. PubMed ID: 8138714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the binding and degradation of human very-low-density lipoproteins by human hepatoma cell line HepG2.
    Dashti N; Wolfbauer G
    Biochim Biophys Acta; 1986 Feb; 875(3):473-86. PubMed ID: 3004589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zonal distribution of receptor binding of trypsin-activated alpha 2-macroglobulin, alpha 2-macroglobulin receptor-associated protein, lactoferrin and transferrin on rat liver parenchymal cells.
    Voorschuur AH; Kuiper J; Van Noort WL; Van Berkel TJ
    Biochim Biophys Acta; 1995 Aug; 1257(3):288-92. PubMed ID: 7544160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nickel is a specific inhibitor for the binding of activated alpha 2-macroglobulin to the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor.
    Hussain MM; Kancha RK; Tulenko TN
    Biochemistry; 1995 Dec; 34(49):16074-81. PubMed ID: 8519764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic uptake of beta-VLDL in cholesterol-fed rabbits.
    Gudmundsen O; Berg T; Roos N; Nenseter MS
    J Lipid Res; 1993 Apr; 34(4):589-600. PubMed ID: 8388430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of the roles of the low density lipoprotein (LDL) receptor and the LDL receptor-related protein/alpha 2-macroglobulin receptor in chylomicron remnant removal in the mouse in vivo.
    Choi SY; Cooper AD
    J Biol Chem; 1993 Jul; 268(21):15804-11. PubMed ID: 7687998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor.
    Herz J; Goldstein JL; Strickland DK; Ho YK; Brown MS
    J Biol Chem; 1991 Nov; 266(31):21232-8. PubMed ID: 1718973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of apo E-containing lipoproteins with the LDL receptor-related protein LRP.
    Küchenhoff A; Harrach-Ruprecht B; Robenek H
    Am J Physiol; 1997 Feb; 272(2 Pt 1):C369-82. PubMed ID: 9124278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance.
    Willnow TE; Goldstein JL; Orth K; Brown MS; Herz J
    J Biol Chem; 1992 Dec; 267(36):26172-80. PubMed ID: 1464627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transport of beta-very low density lipoproteins and chylomicron remnants by macrophages is mediated by the low density lipoprotein receptor pathway.
    Ellsworth JL; Kraemer FB; Cooper AD
    J Biol Chem; 1987 Feb; 262(5):2316-25. PubMed ID: 3546288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uptake of canine beta-very low density lipoproteins by mouse peritoneal macrophages is mediated by a low density lipoprotein receptor.
    Koo C; Wernette-Hammond ME; Innerarity TL
    J Biol Chem; 1986 Aug; 261(24):11194-201. PubMed ID: 3733751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein.
    Kowal RC; Herz J; Weisgraber KH; Mahley RW; Brown MS; Goldstein JL
    J Biol Chem; 1990 Jun; 265(18):10771-9. PubMed ID: 2355022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of lecithin:cholesterol acyltransferase (LCAT).alpha 2-macroglobulin complex with low density lipoprotein receptor-related protein (LRP). Evidence for an alpha 2-macroglobulin/LRP receptor-mediated system participating in LCAT clearance.
    Krimbou L; Marcil M; Davignon J; Genest J
    J Biol Chem; 2001 Aug; 276(35):33241-8. PubMed ID: 11435418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of lipoprotein receptors on rat Fu5AH hepatoma cells.
    Friedman G; Wernette-Hammond ME; Hui DY; Mahley RW; Innerarity TL
    J Lipid Res; 1987 Dec; 28(12):1482-94. PubMed ID: 2828502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete down-regulation of low-density-lipoprotein-receptor activity in the human hepatoma cell line Hep G2 by beta-migrating very-low-density lipoprotein and non-lipoprotein cholesterol. Different cellular regulatory pools of cholesterol.
    Kamps JA; van Berkel TJ
    Eur J Biochem; 1992 Jun; 206(3):973-8. PubMed ID: 1318843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins (beta-VLDL) and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein.
    Weisgraber KH; Mahley RW; Kowal RC; Herz J; Goldstein JL; Brown MS
    J Biol Chem; 1990 Dec; 265(36):22453-9. PubMed ID: 2266137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia.
    Ji ZS; Fazio S; Mahley RW
    J Biol Chem; 1994 May; 269(18):13421-8. PubMed ID: 8175773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic triglyceride lipase promotes low density lipoprotein receptor-mediated catabolism of very low density lipoproteins in vitro.
    Medh JD; Bowen SL; Fry GL; Ruben S; Hill J; Wong H; Chappell DA
    J Lipid Res; 1999 Jul; 40(7):1263-75. PubMed ID: 10393211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.